image of Translational Cancer Research

Translational Cancer Research

Editors:
AME
Publisher:
AME Publishing Company
2024 Journal Impact Factor:
1.7 (Journal Citation Report, Web of Science Group)
ISSN:
2218-676X
Print/PDF
Add to Ovid Subscription
Register for eToc Alerts
View Popular Articles
  • Description
  • Details
Description
Translational Cancer Research is an Open Access, peer-reviewed journal.

TCR publishes laboratory studies of novel therapeutic interventions as well as clinical trials which evaluate new treatment paradigms for cancer, results of novel research investigations which bridge the laboratory and clinical settings including risk assessment, cellular and molecular characterization, prevention, detection, diagnosis and treatment of human cancers with the overall goal of improving the clinical care of cancer patients. Published bimonthly from Jun. 2012 to Aug. 2019, TCR now follows a monthly publication model.

The focus of TCR is original, peer-reviewed, science-based research that successfully advances clinical medicine toward the goal of improving patients' quality of life. The editors and an international advisory group of scientists and clinician-scientists as well as other experts will hold TCR articles to the high-quality standards.
Details
Platform:
OvidSP
Publisher:
AME Publishing Company
Product Type:
Journal
Author:
AME
ISSN:
2218-676X
Specialty:
  • Internal Medicine
  • Oncology
Language:
English
Update Frequency:
Semi-Monthly
2024 Journal Impact Factor:
1.7 (Journal Citation Report, Web of Science Group)

Request Information

Back To Top